Cellectis S.A. (CLLS) Total liabilities 2016–2025
Cellectis S.A. (CLLS) total liabilities at each fiscal year-end, per SEC filings.
$248.8MFY2025 · since FY2016: $58.6M → $248.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $248.8M | -1.5% |
| FY2024 | $252.5M | +1.2% |
| FY2023 | $249.6M | +74.2% |
| FY2022 | $143.2M | -10.9% |
| FY2021 | $160.8M | -13.4% |
| FY2020 | $185.7M | +21.9% |
| FY2019 | $152.3M | +66.4% |
| FY2018 | $91.5M | +34.6% |
| FY2017 | $68.0M | +16.0% |
| FY2016 | $58.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLLS financial trends
CLLS RevenueCLLS Net incomeCLLS Net marginCLLS Gross profitCLLS Gross marginCLLS Operating incomeCLLS Operating marginCLLS Operating cash flowCLLS Free cash flowCLLS Capital expendituresCLLS Return on equityCLLS Stock buybacksCLLS Dividends paidCLLS Total assetsCLLS Shareholders’ equityCLLS overview →